The subject expert committee (SEC) under India's drug regulator is expected to review the EUA applications of drug companies seeking approval for Merck’s antiviral pill, Molnupiravir, on Thursday.Wednesday, 17 November 2021
https://ift.tt/3cmeWEd panel to review EUA application for generic Covid-19 pill
The subject expert committee (SEC) under India's drug regulator is expected to review the EUA applications of drug companies seeking approval for Merck’s antiviral pill, Molnupiravir, on Thursday.
0 Comments:
Post a Comment